Latest Chemotherapy news
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
posted February 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Four in 10 Patients Receiving Chemo Develop Chronic Painful Neuropathy
posted February 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Dual-Targeted Therapies Plus Chemo Improve Objective Response Rate in BRAF V600E Metastatic CRC
posted February 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Perioperative Chemo With FLOT Ups Survival in Resectable Esophageal Cancer
posted January 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Local Recurrence Rate Low After R0 Resection of Soft Tissue Sarcoma Tumors 
Postoperative Complications Elevated for Patients With Systemic Lupus Erythematosus 
Response to Autologous HSCT Durable for Patients With Systemic Sclerosis 
Early Survivorship Care Linked to Improved Outcomes in Head, Neck Cancer 
Relapse Rare After Appendiceal Adenocarcinoma Resection 
Cancer Drug Shortages Persist at All Cancer Centers 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer Monthly Specialist Briefings
Stay Connected
